Skip to main content
SpringerLink
Log in

Glivec EU-SPC updated following safety concerns

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Novartis Pharmaceuticals UK Ltd.Congestive heart failure and left ventricular dysfunction in Glivec treated patients. Company Communication: [2 pages], 9 Jan 2007. Available from: URL: http://www.mhra.gov.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glivec EU-SPC updated following safety concerns. React. Wkly. 1135, 2 (2007). https://doi.org/10.2165/00128415-200711350-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711350-00002

Keywords

Search

Navigation